147 related articles for article (PubMed ID: 9409220)
21. Inhibition of late vein graft neointima formation in human and porcine models by adenovirus-mediated overexpression of tissue inhibitor of metalloproteinase-3.
George SJ; Lloyd CT; Angelini GD; Newby AC; Baker AH
Circulation; 2000 Jan; 101(3):296-304. PubMed ID: 10645926
[TBL] [Abstract][Full Text] [Related]
22. Gene transfer of tissue inhibitor of metalloproteinase-2 inhibits metalloproteinase activity and neointima formation in human saphenous veins.
George SJ; Baker AH; Angelini GD; Newby AC
Gene Ther; 1998 Nov; 5(11):1552-60. PubMed ID: 9930309
[TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinase 2 (gelatinase A) is related to migration of keratinocytes.
Mäkelä M; Larjava H; Pirilä E; Maisi P; Salo T; Sorsa T; Uitto VJ
Exp Cell Res; 1999 Aug; 251(1):67-78. PubMed ID: 10438572
[TBL] [Abstract][Full Text] [Related]
24. Expression of membrane-type 1 matrix metalloproteinase in coronary vessels of allotransplanted primate hearts.
Tsukioka K; Suzuki J; Kawauchi M; Wada Y; Zhang T; Nishio A; Koide N; Endoh M; Takayama K; Takamoto S; Isobe M; Amano J
J Heart Lung Transplant; 2000 Dec; 19(12):1193-8. PubMed ID: 11124489
[TBL] [Abstract][Full Text] [Related]
25. Marimastat inhibits neointimal thickening in a model of human vein graft stenosis.
Porter KE; Loftus IM; Peterson M; Bell PR; London NJ; Thompson MM
Br J Surg; 1998 Oct; 85(10):1373-7. PubMed ID: 9782017
[TBL] [Abstract][Full Text] [Related]
26. All-trans-retinoic acid decreases vein graft intimal hyperplasia and matrix metalloproteinase activity in vivo.
Leville CD; Dassow MS; Seabrook GR; Jean-Claude JM; Towne JB; Cambria RA
J Surg Res; 2000 May; 90(2):183-90. PubMed ID: 10792961
[TBL] [Abstract][Full Text] [Related]
27. Androgens regulate MMPs and the cellular processes of intimal hyperplasia.
Mountain DJ; Freeman BM; Kirkpatrick SS; Beddies JW; Arnold JD; Freeman MB; Goldman MH; Stevens SL; Klein FA; Grandas OH
J Surg Res; 2013 Sep; 184(1):619-27. PubMed ID: 23773714
[TBL] [Abstract][Full Text] [Related]
28. In vivo suppression of vein graft disease by nonviral, electroporation-mediated, gene transfer of tissue inhibitor of metalloproteinase-1 linked to the amino terminal fragment of urokinase (TIMP-1.ATF), a cell-surface directed matrix metalloproteinase inhibitor.
Eefting D; de Vries MR; Grimbergen JM; Karper JC; van Bockel JH; Quax PH
J Vasc Surg; 2010 Feb; 51(2):429-37. PubMed ID: 20036101
[TBL] [Abstract][Full Text] [Related]
29. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
30. Expression of matrix metalloproteinases (MMP-1 and -2) and their inhibitors (TIMP-1, -2 and -3) in oral lichen planus, dysplasia, squamous cell carcinoma and lymph node metastasis.
Sutinen M; Kainulainen T; Hurskainen T; Vesterlund E; Alexander JP; Overall CM; Sorsa T; Salo T
Br J Cancer; 1998 Jun; 77(12):2239-45. PubMed ID: 9649139
[TBL] [Abstract][Full Text] [Related]
31. Expression and localization of TIMP-1, TIMP-2, MMP-13, MMP-2, and MMP-9 in early and advanced experimental lung silicosis.
Pardo A; Pérez-Ramos J; Segura-Valdez L; Ramírez R; Selman M
Ann N Y Acad Sci; 1999 Jun; 878():587-9. PubMed ID: 10415781
[No Abstract] [Full Text] [Related]
32. Tumor-stromal cell contact promotes invasion of human uterine cervical carcinoma cells by augmenting the expression and activation of stromal matrix metalloproteinases.
Sato T; Sakai T; Noguchi Y; Takita M; Hirakawa S; Ito A
Gynecol Oncol; 2004 Jan; 92(1):47-56. PubMed ID: 14751137
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of intracellular Ca2+ mobilisation by low antiproliferative concentrations of thapsigargin in human vascular smooth-muscle cells.
Birkett SD; Jeremy JY; Watts SM; Shukla N; Angelini GD; McArdle CA
J Cardiovasc Pharmacol; 1999 Feb; 33(2):204-11. PubMed ID: 10028927
[TBL] [Abstract][Full Text] [Related]
34. Inhibition of Intimal Thickening By PRH (Proline-Rich Homeodomain) in Mice.
Reolizo LM; Williams H; Wadey K; Frankow A; Li Z; Gaston K; Jayaraman PS; Johnson JL; George SJ
Arterioscler Thromb Vasc Biol; 2023 Mar; 43(3):456-473. PubMed ID: 36700427
[TBL] [Abstract][Full Text] [Related]
35. Pressure distention compared with pharmacologic relaxation in vein grafting upregulates matrix metalloproteinase-2 and -9.
Chung AW; Rauniyar P; Luo H; Hsiang YN; van Breemen C; Okon EB
J Vasc Surg; 2005 Oct; 42(4):747-56. PubMed ID: 16242564
[TBL] [Abstract][Full Text] [Related]
36. [Role of cytokine-matrix metalloproteinase axis on promoting vascular neointima hyperplasia in mice].
Liu Y; Ning WH; Shen XH; Guo DL; Guo L
Zhonghua Xin Xue Guan Bing Za Zhi; 2016 Nov; 44(11):961-967. PubMed ID: 27903395
[No Abstract] [Full Text] [Related]
37. Regulation of cell-matrix contacts and beta-catenin signaling in VSMC by integrin-linked kinase: implications for intimal thickening.
Dwivedi A; Sala-Newby GB; George SJ
Basic Res Cardiol; 2008 May; 103(3):244-56. PubMed ID: 18080083
[TBL] [Abstract][Full Text] [Related]
38. Expression of matrix metalloproteinases during murine chorioallantoic placenta maturation.
Teesalu T; Masson R; Basset P; Blasi F; Talarico D
Dev Dyn; 1999 Mar; 214(3):248-58. PubMed ID: 10090151
[TBL] [Abstract][Full Text] [Related]
39. Soluble N-cadherin: A novel inhibitor of VSMC proliferation and intimal thickening.
Lyon CA; Wadey KS; George SJ
Vascul Pharmacol; 2016 Mar; 78():53-62. PubMed ID: 26586312
[TBL] [Abstract][Full Text] [Related]
40. Statins for the prevention of vein graft stenosis: a role for inhibition of matrix metalloproteinase-9.
Porter KE; Turner NA
Biochem Soc Trans; 2002 Apr; 30(2):120-6. PubMed ID: 12023838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
